BRAMPTON, ON-- Medtronic of Canada today announced it has received Health Canada license for the Reveal LINQ Insertable Cardiac Monitor (ICM), the smallest implantable cardiac monitoring device ...
Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy “In the current COVID-19 environment, the LINQ II system offers patients a seamless way to experience ...
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...
The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...
ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients Over the first year, 12.5%* of patients in the ICM arm had ...
Medtronic this week received regulatory approval for use of an implantable cardiac monitor in pediatric patients, giving doctors and parents greater peace of mind about the device's safety. On Tuesday ...
FRESNO, Calif. (KFSN) -- More than two million people in the U.S. have atrial fibrillation - an abnormal heart rhythm that can lead to stroke or heart failure. Now a new device, about one-third the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results